---
layout: report
type: weekly
topic_slug: chronic_migraine
topic_display: "Chronic Migraine"
week_start: 2025-08-25
week_end: 2025-08-31
permalink: /topics/chronic_migraine/weekly/2025-08-25/
source_run_ids:
  - chronic_migraine_20250826_091029
  - chronic_migraine_20250827_091408
  - chronic_migraine_20250828_091013
  - chronic_migraine_20250829_141515
  - chronic_migraine_20250830_090920
topics_covered:
  - Chronic Migraine
---

# Weekly Research Summary: Chronic Migraine

**Disclaimer:** This summary is generated by an AI assistant and is for informational purposes only. It is not a substitute for professional medical advice. Always consult with a qualified healthcare provider for any health concerns or before making any decisions related to your health or treatment.
---
### **TL;DR: Key Takeaways This Week**
- **Symptom tracking is foundational for all aspects of chronic migraine management,** enabling personalized treatment, trigger identification, and effective communication with healthcare providers.
- **New CGRP-targeted therapies (monoclonal antibodies, gepants, nasal sprays) offer diverse, precision options** for both acute and preventive treatment, often with better tolerability and reduced risk of medication overuse headache compared to older drugs.
- **Caretakers play a vital role in acute attack management,** from preparing comfort kits to understanding acute medications and recognizing critical red-flag symptoms that necessitate immediate medical attention.
---
## Detailed Synthesis

### The Indispensable Role of Symptom Tracking

Across all stages of chronic migraine management, from initial diagnosis to ongoing treatment, consistent and detailed symptom tracking emerges as the single most critical tool. For newly diagnosed patients, tracking helps uncover unique migraine patterns, identify triggers (e.g., specific foods, stress, sleep patterns), and inform early intervention strategies. By recognizing prodromal symptoms, patients can take acute medication at the optimal time, enhancing its effectiveness. For both patients and caretakers, a migraine diary is invaluable for objectively monitoring the efficacy of acute and preventive medications, noting side effects, and providing essential data for informed discussions with neurologists. This data-driven approach empowers individuals to actively participate in refining their personalized treatment plans and improving their quality of life.

### Advancements in CGRP-Targeted Therapies: A New Era

This week highlighted significant progress in migraine prevention and acute treatment through therapies targeting Calcitonin Gene-Related Peptide (CGRP). These precision-targeted medications work by blocking CGRP or its receptor, a key pathway in migraine pain.

For **prevention**, CGRP monoclonal antibodies (mAbs) like erenumab, fremanezumab, galcanezumab, and eptinezumab offer a new approach, particularly for those with frequent migraines who haven't responded to traditional preventives. Administered via subcutaneous injection (monthly/quarterly) or intravenous infusion (quarterly), these mAbs are generally well-tolerated, though side effects like injection site reactions or constipation can occur.

For both **acute and preventive treatment**, oral gepants (ubrogepant, rimegepant, atogepant) provide flexible pill-based options. Rimegepant is unique in its dual approval for both acute, as-needed use and every-other-day prevention. Atogepant is a daily preventive, while ubrogepant is solely for acute attacks. A notable advantage of gepants and ditans (e.g., lasmiditan) over triptans is their potential safety for patients with cardiovascular concerns, as they do not cause vasoconstriction. Additionally, the CGRP inhibitor nasal spray, zavegepant, offers rapid acute relief, especially beneficial for those with quick-onset migraines or severe nausea. Common side effects for gepants and nasal sprays include nausea, fatigue, and altered taste or nasal discomfort, respectively.

### Optimizing Acute Migraine Management and Preventing Medication Overuse

Effective acute treatment is crucial for managing chronic migraine attacks. While NSAIDs can address mild attacks, targeted options like triptans remain a cornerstone for moderate to severe migraines. However, their use is strictly limited (typically 9 days per month) to prevent Medication Overuse Headache (MOH), a condition where frequent acute medication use paradoxically worsens headaches. Triptans are also contraindicated for individuals with uncontrolled hypertension or heart disease. Newer options like gepants and ditans provide valuable alternatives, as they generally carry a lower risk of MOH and can be safer for patients with cardiovascular issues.

Caretakers play a pivotal role in administering acute medications promptly and observing their effectiveness and side effects. Beyond pharmacological interventions, a personalized "comfort kit" can significantly enhance relief for a loved one experiencing an acute attack. This kit might include sensory relief items (eye masks, noise-canceling headphones), non-pharmacological pain relief (topical gels, acupressure), hydration, and gentle distractions, always used in consultation with a healthcare provider.

### Caretaker Empowerment and Emergency Preparedness

Understanding when to seek emergency care is a critical responsibility for caretakers. While managing severe migraines at home, it's vital to distinguish typical migraine symptoms from medical emergencies. Immediate 911 calls are warranted for sudden, severe "thunderclap" headaches (potentially indicating a subarachnoid hemorrhage) or acute neurological changes like weakness, speech difficulties, or vision changes beyond typical aura (suggesting stroke or seizure). Urgent evaluation in an emergency room is advised for headaches accompanied by fever, stiff neck, or rash (meningitis), headaches following head trauma, new headaches in individuals over 50 (to rule out serious conditions), or concerning shifts in the usual migraine pattern. During an emergency, keeping the patient calm and comfortable in a dark, quiet room is recommended, and no additional medication should be administered unless instructed by emergency personnel. Trusting one's instincts and seeking prompt evaluation can be life-saving.

**week_topics:**
- Chronic Migraine Management
- CGRP Therapies
- Acute Migraine Treatment
- Migraine Prevention
- Symptom Tracking
- Caretaker Role in Migraine
- Emergency Migraine Symptoms
- Medication Overuse Headache
